Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DCLK1 encodes a member of the protein kinase superfamily and the doublecortin family. Additionally we are shipping DCLK1 Kits (24) and DCLK1 Proteins (17) and many more products for this protein.
Showing 10 out of 116 products:
Human Polyclonal DCLK1 Primary Antibody for IF, IHC (p) - ABIN391324
Gerbe, Brulin, Makrini, Legraverend, Jay: DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium. in Gastroenterology 2009
Show all 12 references for 391324
Human Polyclonal DCLK1 Primary Antibody for WB - ABIN391323
Matsumoto, Pilz, Ledbetter: Genomic structure, chromosomal mapping, and expression pattern of human DCAMKL1 (KIAA0369), a homologue of DCX (XLIS). in Genomics 1999
Show all 8 references for 391323
Human Monoclonal DCLK1 Primary Antibody for IF, WB - ABIN393872
Rose, Behm, Drgon, Johnson, Uhl: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. in Molecular medicine (Cambridge, Mass.) 2010
Show all 5 references for 393872
Human Polyclonal DCLK1 Primary Antibody for EIA, WB - ABIN359413
Sossey-Alaoui, Srivastava: DCAMKL1, a brain-specific transmembrane protein on 13q12.3 that is similar to doublecortin (DCX). in Genomics 1999
Show all 4 references for 359413
Human Polyclonal DCLK1 Primary Antibody for EIA, IHC (p) - ABIN359414
Omori, Suzuki, Ozaki, Harada, Nakamura, Takahashi, Fujiwara: Expression and chromosomal localization of KIAA0369, a putative kinase structurally related to Doublecortin. in Journal of human genetics 1998
Show all 4 references for 359414
These results suggest that both the kinase domain and the Ser (show SIGLEC1 Antibodies)/Pro-rich domain are involved in regulating the microtubule-binding activity of doublecortin (show DCX Antibodies)-like protein kinase (show TGFB3 Antibodies) (DCLK (show DCLK2 Antibodies)).
DCLK (show DCLK2 Antibodies) mediates its neuronal functions through phosphorylation of physiological substrates such as synapsin II (show SYN2 Antibodies)
Gene knockdown studies of zDCLK (show DCLK2 Antibodies) suggest that zDCLK (show DCLK2 Antibodies) may play crucial roles in the central nervous systems during the early stage of embryogenesis.
Our results indicate that Dclk1 is essential in advancing intestinal tumorigenesis. Knocking down Dclk1 decreases tumor stemness and progression and is thus predicted to regulate pro-survival signaling and tumor cell pluripotency.
The univariate and multivariate analyses suggested DCAMKL1 protein overexpression was an unfavorable prognostic factor in bladder cancer patients. In conclusion, DCAMKL1 is an independent poor prognostic factor for bladder cancer patients.
DCLK1 induction and its overexpression following hepatic injury are likely to contribute to tumorigenesis including maintenance and dissemination of tumor cells in circulation.
first evidence for the suppressive activity of miR (show MLXIP Antibodies)-613 in hepatocellular carcinoma, which is causally linked to targeting of DCLK1
MSX1 (show MSX1 Antibodies) and DCLK1 might be used in colorectal cancer detection or as target of cancer therapies.
Increased expression of stromal DCLK1 was detected in endometriotic tissue compared to endometriosis patient endometrium. Stromal expression of DCLK1 was increased in endometrium of endometriosis patients compared to controls.
DCLK1 up-regulation may play a contributory role in colorectal cancer metastasis and poor prognosis via activation of EMT (show ITK Antibodies). DCLK1 may serve as an independent predictor for CRC (show CALR Antibodies) prognosis.
Results showed the mechanism in which miR (show MLXIP Antibodies)-137 regulates the expression of DCLK1, and demonstrated the opposite expression patterns of miR (show MLXIP Antibodies)-137/DCLK1 in human non-small cell lung carcinoma and colon cancer stem cells.
DCLK1 promoter methylationis associated with lung cancer.
DCLK1 expression could aid in the prognostication and management of breast cancer with neuroendocrine differentiation.
Dclk1 contributes functionally to the pathogenesis of pancreatic cancer; Dclk1 marks quiescent pancreatic progenitors that are candidates for the origin of pancreatic cancer
loss of parietal cells leads to the reversible emergence of a novel Dclk1-expressing sensory cell population in the gastric mucosa.
Dclk1 plays an important role in regulating colonic inflammatory response and colonic epithelial integrity
Dclk1 promotes axonal regeneration, neuronal survival, and growth core reformation via microtubule stabilization, prevention of F-actin destabilization and synergy with mTOR (show FRAP1 Antibodies).
Dclk1 is critically involved in facilitating intestinal tumorigenesis by enhancing pluripotency and EMT (show ITK Antibodies) factors in Apc (show APC Antibodies) mutant intestinal tumors and it also provides a potential therapeutic target for the treatment of colorectal cancer.
Dclk1 plays a functional role critical in the epithelial restorative response.
DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.
These results suggest that crypt epithelial cell Dclk1 expression can be used as one potential marker to evaluate the early survival of intestinal stem cells following severe radiation injury.
Pancreatic neoplasms in mice contain morphologically and functionally distinct subpopulations, expressing DCLK1, that have cancer stem cell-like properties.
DCAMKL1 represses osteoblast activation by antagonizing Runx2 (show RUNX2 Antibodies), the master transcription factor in osteoblasts.
This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. The encoded protein is involved in several different cellular processes, including neuronal migration, retrograde transport, neuronal apoptosis and neurogenesis. This gene is up-regulated by brain-derived neurotrophic factor and associated with memory and general cognitive abilities. Multiple transcript variants generated by two alternative promoter usage and alternative splicing have been reported, but the full-length nature and biological validity of some variants have not been defined. These variants encode different isoforms, which are differentially expressed and have different kinase activities.
doublecortin-like kinase 1
, doublecortin and CaM kinase-like 1
, doublecortin and calcium/calmodulin-dependent protein kinase-like 1
, serine/threonine-protein kinase DCLK1
, doublecortin-like kinase 2
, serine/threonine-protein kinase DCLK1-like
, doublecortin domain-containing protein 3A
, doublecortin-like and CAM kinase-like 1
, CLICK-I beta
, double cortin and calcium/calmodulin-dependent protein kinase-like 1